Last update:

Medications news

Medications

Trend toward survival benefit seen for REM-inhibition in ALS

For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward survival benefit, according to a study presented at the ...

Medications

New combination therapy found safe and feasible for neuroendocrine tumor patients

A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been deemed feasible and tolerable for neuroendocrine cancer patients. The combined therapy works by preventing ...

Medications

Survey: One in three supplements contain banned substances

Sport Integrity Australia (SIA) has released the findings of a major survey of sports supplements available in the Australian online marketplace, revealing a significant and continuing risk for athletes. The results are published ...

Medications

ALS drug effectively treats Alzheimer's disease in animal study

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS)—improves neuron health in animal models ...

Medications

Drug combo offers hope for advanced bladder cancer patients

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary bladder and the upper part of the urethra. In the vast majority of cases, urothelial carcinomas ...

Medications

Study exposes huge levels of untargeted antibiotic prescribing

Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of prognosis and the risk of the infection worsening, according to a new study led by University of Manchester ...

Medications

Q&A: How can drug repurposing lower drug costs and improve care?

Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States topped $722 billion, a trend that's expected to continue. Yet, nearly 30% struggle to pay for their prescriptions ...